News
TKNO
3.990
+4.72%
0.180
Weekly Report: what happened at TKNO last week (0504-0508)?
Weekly Report · 2d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Voyager Therapeutics (VYGR), Alpha Teknova (TKNO) and RxSight (RXST)
TipRanks · 4d ago
Alpha Teknova Charts Cautious Path to 2027 Growth
TipRanks · 5d ago
Alpha Teknova GAAP EPS of -$0.08 beats by $0.01, revenue of $11.07M beats by $0.85M
Seeking Alpha · 5d ago
Alpha Teknova reports Q1 EPS (8c) vs. (9c) last year
TipRanks · 6d ago
Alpha Teknova backs FY26 revenue view $42M-$44M, consensus $43.01M
TipRanks · 6d ago
Alpha Teknova Q1 revenue rises, beats estimates
Reuters · 6d ago
*Alpha Teknova 1Q Loss/Shr 8c >TKNO
Dow Jones · 6d ago
*Alpha Teknova 1Q Rev $11.1M >TKNO
Dow Jones · 6d ago
Alpha Teknova Affirms FY2026 Sales Guidance of $42.000M-$44.000M vs $43.013M Est
Benzinga · 6d ago
Alpha Teknova Q1 EPS $(0.08) Beats $(0.09) Estimate, Sales $11.077M Beat $10.214M Estimate
Benzinga · 6d ago
Press Release: Teknova Reports First Quarter 2026 Financial Results
Dow Jones · 6d ago
Alpha Teknova: Q1 Earnings Snapshot
Barchart · 6d ago
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD)
TipRanks · 05/06 07:30
Weekly Report: what happened at TKNO last week (0427-0501)?
Weekly Report · 05/04 09:19
Weekly Report: what happened at TKNO last week (0420-0424)?
Weekly Report · 04/27 09:20
Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO), West Pharmaceutical Services (WST) and LENZ Therapeutics (LENZ)
TipRanks · 04/23 16:52
Teknova to report first-quarter financial results after market close
PUBT · 04/22 20:01
Alpha Teknova announces annual shareholder meeting
PUBT · 04/21 21:24
Weekly Report: what happened at TKNO last week (0413-0417)?
Weekly Report · 04/20 09:19
More
Webull provides a variety of real-time TKNO stock news. You can receive the latest news about Alpha Teknova through multiple platforms. This information may help you make smarter investment decisions.
About TKNO
Alpha Teknova, Inc. is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The Company offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.